- 23261
23261
氯甲酸三氯甲酯
≥97.0% (GC)
Recommended Products
质量水平
测定
≥97.0% (GC)
折射率
n20/D 1.458
bp
20 °C/10 mmHg (lit.)
密度
1.639 g/mL at 20 °C
储存温度
2-8°C
SMILES string
ClC(=O)OC(Cl)(Cl)Cl
InChI
1S/C2Cl4O2/c3-1(7)8-2(4,5)6
InChI key
HCUYBXPSSCRKRF-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Related Categories
Compare Similar Items
View Full Comparison1 of 4
This Item | 142077 | 23181 | 252514 |
|---|---|---|---|
| assay ≥97.0% (GC) | assay 98% | assay ≥98.0% (GC) | assay 97% |
| refractive index n20/D 1.458 | refractive index n20/D 1.471 (lit.) | refractive index n20/D 1.428 | refractive index n20/D 1.446 (lit.) |
| bp 20 °C/10 mmHg (lit.) | bp 171-172 °C (lit.) | bp 107-108 °C (lit.) | bp 155-156 °C (lit.) |
| density 1.639 g/mL at 20 °C | density 1.539 g/mL at 25 °C (lit.) | density 1.450 g/mL at 20 °C | density 1.385 g/mL at 25 °C (lit.) |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
| Quality Level 100 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
应用
- 使用单膦金（i）催化剂的环状氨基甲酰亚胺酯
- N-烯基和环烷基氨基甲酸酯作为双重作用的组胺 H3 和 H4 受体配体
- 前列腺特异性膜抗原靶向抗癌前药
- 潜在的西尼罗河病毒蛋白酶抑制剂
- 抗体 - 药物偶联物（ADC）
- 红霉素 A 衍生物
TCF 也可用于：
- 合成 N-羧基 α-氨基酸酐。
- 作为酰化剂，由 α-氨基醇合成恶唑烷酮。
- 作为脱水剂，在三乙胺存在下合成芳香族二异氰化物。
其他说明
警示用语：
Danger
危险分类
Acute Tox. 2 Inhalation - Acute Tox. 4 Oral - Skin Corr. 1B
储存分类代码
6.1B - Non-combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials
WGK
WGK 3
闪点(F)
Not applicable
闪点(C)
Not applicable
个人防护装备
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
Certificate of Analysis
Enter Lot Number to search for Certificate of Analysis (COA).
Certificate of Origin
Enter Lot Number to search for Certificate of Origin (COO).
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service